Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02393248
Recruitment Status : Active, not recruiting
First Posted : March 19, 2015
Last Update Posted : March 3, 2021
Sponsor:
Information provided by (Responsible Party):
Incyte Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : December 14, 2020
Estimated Study Completion Date : May 30, 2021